FDA 483 - Laboratorios Farmaceuticos Rovi S.A. - June 29, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Laboratorios Farmaceuticos Rovi S.A.'s chemical and physical testing laboratory in Alcala De Henares, Madrid, Spain, revealed significant deficiencies. The firm's quality control unit failed to follow written procedures for out-of-specification investigations, maintain data integrity, and control laboratory documentation. Additionally, the inspection found inadequate performance qualification procedures and execution for critical laboratory equipment.
ID · c56c8e0a-34bb-4118-b3b4-f299ee48bb51